Stephen N. Keith, MD, MSPH is senior medical director of Syneos Health, a global clinical research organization. He has served as the lead Medical Monitor on a broad range of neurologic, infectious disease and other clinical trials, and is actively engaged in efforts to increase racial and ethnic diversity in clinical trials both outside and within the company.

Previous roles include CEO of Vivacelle Bio, Inc.; CEO of the American College of Clinical Pharmacology; President and Chief Operating Officer of Panacea Pharmaceuticals, Inc.; General Partner with Emerging Technology Partners; President and Chief Operating Officer, Antex Biologics Inc.; Vice President, Marketing and Sales, at North American Vaccine, Inc. and various positions at Merck & Co., Inc.

Dr. Keith earned a bachelor’s degree from Amherst College, an M.D. from the University of Illinois, a Masters in Science in Public Health from UCLA, and completed his residency in pediatrics and fellowship as a Robert Wood Johnson Clinical Scholar at the University of California, Los Angeles.

Dr. Keith is a Fellow of the Academy of Pediatrics and a Diplomate of the American Board of Pediatrics. He has three adult children, and his wife, Helene Gayle MD, MPH, is the President of Spelman College in Atlanta.